
About Summit:
Summit Therapeutics Inc. is a biopharmaceutical oncology company with a mission focused
on improving quality of life, increasing potential duration of life, and resolving serious unmet
medical needs. At Summit, we believe in building a team of world class professionals who
are passionate about this mission, and it is our people who drive this mission to reality.
Summit’s core values include integrity, passion for excellence, purposeful urgency,
collaboration, and our commitment to people. Our employees are truly the heart and soul of
our culture, and they are invaluable in shaping our journey toward excellence.
Summit’s team is inspired to touch and help change lives through Summit’s clinical
studies in the field of oncology. Summit has multiple global Phase 3 clinical studies,
including:
Non-small Cell Lung Cancer (NSCLC)
combined with chemotherapy compared to placebo plus chemotherapy in patients
with EGFR-mutated, locally advanced or metastatic non-squamous NSCLC who
were previously treated with a 3rd generation EGFR TKI.
combined with chemotherapy compared to pembrolizumab combined with
chemotherapy in patients with first-line metastatic NSCLC.
monotherapy compared to pembrolizumab monotherapy in patients with first-line
metastatic NSCLC.
Colorectal Cancer (CRC)
combination with chemotherapy compared with bevacizumab plus chemotherapy.
Ivonescimab is an investigational therapy not presently approved by any regulatory authority other than China’s National Medical Products Administration (NMPA). Summit is headquartered in Miami, Florida, and has additional offices in California, New Jersey, the UK, and Ireland.
of Role:
Serves as the study-level biostatistician including reviewing protocol, conducting sample size calculations, developing statistical analysis plan, data presentation plan, and Data Monitoring Committee (DMC) charter, reviewing study documents (e.g., CRFs, ADaM specifications, statistical outputs, etc.) for clinical trials in oncology. Partners with cross-functional team members in ensuring accuracy/consistency of clinical data and exceptional delivery, interpretation of clinical results, and assists in the development and review of regulatory submission documents. Implements biostatistics department policies, standards, procedures, and work instructions.
Role and Responsibilities:
Experience, Education and Specialized Knowledge and Skills:
The pay range for this role is $245,000 to $307,000 annually. Actual compensation packages are based on several factors that are unique to each candidate, including but not limited to skill set, depth of experience, certifications, and specific work location. This may be different in other locations due to differences in the cost of labor. The total compensation package for this position may also include bonus, stock, benefits and/or other applicable variable compensation.
Summit does not accept referrals from employment businesses and/or employment agencies in respect of the vacancies posted on this site. All employment businesses/agencies are required to contact Summit’s human resources department to obtain prior written authorization before referring any candidates to Summit.

Summit Mission Statement:
To build a viable, long-lasting health care organization that assumes full responsibility for designing, developing, trial execution and enrollment, regulatory submission and approval, as well as successful commercialization of patient, physician, caregiver, and societal-friendly medicinal therapy intended to: improve quality of life, increase potential duration of life, and resolve serious medical healthcare needs. To identify and control promising product candidates based on exceptional scientific development and administrational expertise, develop our products in a rapid, cost-efficient manner, and to engage commercialization and/or development partners when appropriate.
We accomplish this by building a team of world class professional scientists and business administrators that apply their experience and knowledge to this mission. Team Summit exists to pose, strategize, and execute a path forward in medicinal therapeutic health care that places Summit in a well-deserved, top market share, leadership position. Team Summit assumes full responsibility for stimulating continuous expansion of knowledge, ability, capability, and well-being for all involved stakeholders and highly-valued shareholders.
Summit was founded in 2003 and our shares are listed on the Nasdaq Global Market (symbol ‘SMMT’). We are headquartered in Miami, Florida, and we have additional offices in Menlo Park, California, and Oxford, UK.